Search results
21 hours ago · Singapore English; 台灣 繁中; UK ... Advancements in treatments, such as Novartis' 177Lu-PSMA-617, which improved survival rates in metastatic castration-resistant prostate cancer, ...
21 hours ago · The Association of the British Pharmaceutical Industry (ABPI) has pulled up four pharmaceutical companies, namely Novartis, Pfizer, Otsuka, and Novo Nordisk, for breaking its code of practice. The ...
7 hours ago · Advancements in treatments, such as Novartis' 177Lu-PSMA-617, which improved survival rates in metastatic castration-resistant prostate cancer, and early diagnosis campaigns are further driving ...
7 hours ago · NOVARTIS AG (ADR) ( NVS) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 87% based on the firm’s underlying fundamentals and the stock’s ...
21 hours ago · 0.90%. Lexicon Pharmaceuticals , Inc. (NASDAQ: LXRX ), a biopharmaceutical company, announced today that Michael Exton, Ph.D., has been appointed as the new Chief Executive Officer and elected to the company's board of directors. Additionally, Jeffrey L. Wade has been promoted to President and Chief Operating Officer.
21 hours ago · Oh SK, Kwon WK, Park S, Ji SG, Kim JH, Park YK, Lee SY, Lim BG. Comparison of Operating Conditions, Postoperative Pain and Recovery, and Overall Satisfaction of Surgeons with Deep vs. No Neuromuscular Blockade for Spinal Surgery under General Anesthesia: A Prospective Randomized Controlled Trial. J Clin Med. 2019 Apr 12;8(4)
6 hours ago · Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today the reintroduction of Susvimo ® (ranibizumab injection) 100 mg/mL for intravitreal use via ocular implant for the treatment of people in the United States (U.S.) with wet, or neovascular, age-related macular degeneration (AMD), following the end of a voluntary recall.
